 |
29 Products |  |
56 Diseases | | 29 Products |
|
154 Trials |  |
7457 News |  |
| «12...86878889909192939495969798» |
- |||||||||| Cimzia (certolizumab pegol) / Astellas, UCB
New P3 trial: CIMPASI-2: A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) (clinicaltrials.gov) - Dec 29, 2014
P3, N=225, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
- |||||||||| Cimzia (certolizumab pegol) / Astellas, UCB
New P3 trial: CIMPASI-1: An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) (clinicaltrials.gov) - Dec 29, 2014
P3, N=225, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
- Zomacton (somatropin) / Ferring
New P2 trial: Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae (clinicaltrials.gov) - Dec 29, 2014
P2, N=20, Not yet recruiting, Sponsor: Tel-Aviv Sourasky Medical Center
- | Firmagon (degarelix) / Astellas, Ferring, Lynparza (olaparib) / Merck (MSD), AstraZeneca
Biomarker, New P1 trial, PARP Biomarker: CaNCaP03: Study of Olaparib ( (clinicaltrials.gov) - Dec 25, 2014
P1, N=20, Not yet recruiting, Sponsor: Cambridge University Hospitals NHS Foundation Trust
- Cervidil (dinoprostone) / Ferring
Trial primary completion date: Foley Catheter Versus Cervidil for Induction of Labor at Term (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=330, Active, not recruiting, Sponsor: Mednax Center for Research, Education and Quality
Trial primary completion date: Aug 2014 --> Aug 2015
- |||||||||| Cimzia (certolizumab pegol) / Astellas, UCB
New P3 trial: RAPID-C OLE: An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 (clinicaltrials.gov) - Dec 19, 2014
P3, N=320, Recruiting, Sponsor: UCB Pharma SA
- Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
Enrollment open: Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation (clinicaltrials.gov) - Dec 17, 2014
P4, N=50, Recruiting, Sponsor: Michigan Reproductive Medicine
Trial primary completion date: Aug 2014 --> Aug 2015 Not yet recruiting --> Recruiting
- Orencia (abatacept) / BMS, Actemra IV (tocilizumab) / Roche, JW Pharma, Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: NORD-STAR: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction (clinicaltrials.gov) - Dec 13, 2014
P4, N=800, Recruiting, Sponsor: Karolinska Institutet
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2017 --> Dec 2018
- ||||| Bravelle (urofollitropin) / Ferring
Enrollment closed, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program (clinicaltrials.gov) - Dec 9, 2014
P3, N=264, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Active, not recruiting
- | Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: SCINTRA: Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNF? in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis (clinicaltrials.gov) - Dec 7, 2014
P3, N=20, Recruiting, Sponsor: University Hospital, Ghent
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2014 --> Sep 2015
- ||||| Rekovelle (follitropin delta) / Ferring
New P2 trial: A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment (clinicaltrials.gov) - Dec 5, 2014
P2, N=144, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- Xtandi (enzalutamide capsule) / Pfizer, Astellas, Mekinist (trametinib) / Novartis, BeiGene, Firmagon (degarelix) / Astellas, Ferring
Enrollment open, Trial initiation date: Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer (clinicaltrials.gov) - Dec 5, 2014
P2, N=45, Recruiting, Sponsor: Jonsson Comprehensive Cancer Center
Trial primary completion date: Sep 2014 --> Sep 2015 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Sep 2014
- |||||| Rebyota (fecal microbiota, live-jslm) / Ferring
New P2b trial: PUNCHCD2: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (clinicaltrials.gov) - Nov 24, 2014
P2b, N=117, Recruiting, Sponsor: Rebiotix Inc.
- || Cervidil (dinoprostone) / Ferring
Trial primary completion date: Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38 (clinicaltrials.gov) - Nov 23, 2014
P2, N=194, Recruiting, Sponsor: Seoul National University Hospital
Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Sep 2014 Trial primary completion date: Dec 2013 --> Dec 2014
- Cimzia (certolizumab pegol) / Astellas, UCB
New P2 trial: RICE: Remission by Intra-articular Injection Plus CErtolizumab (clinicaltrials.gov) - Nov 18, 2014
P2, N=48, Recruiting, Sponsor: R
- || Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date, Metastases: Effectiveness and Safety of Firmagon (clinicaltrials.gov) - Nov 13, 2014
P=N/A, N=200, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2013 --> Dec 2014 Trial primary completion date: Dec 2014 --> Jun 2018
- |||| Pentasa (mesalamine) / Ferring, Takeda
Trial primary completion date, Head-to-Head: CAMMP: Canadian Active & Maintenance Modified Pentasa Study (clinicaltrials.gov) - Nov 12, 2014
P3, N=343, Completed, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2014 --> Jun 2018 Trial primary completion date: Dec 2010 --> May 2011
- |||| Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Nov 7, 2014
P3, N=100, Active, not recruiting, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
Trial primary completion date: Dec 2010 --> May 2011 Trial primary completion date: Dec 2014 --> Oct 2015
- ||||| Lutrelef (gonadorelin acetate) / Ferring
Enrollment change, Trial primary completion date: LutrePulse Hypogonadotropic Hypogonadism (clinicaltrials.gov) - Nov 5, 2014
P3, N=60, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2014 --> Oct 2015 N=36 --> 60 | Trial primary completion date: Feb 2015 --> Apr 2016
- | Xtandi (enzalutamide) / Pfizer, Astellas
New P2 trial: Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer (clinicaltrials.gov) - Oct 30, 2014
P2, N=56, Not yet recruiting, Sponsor: University of Colorado, Denver
- || Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Bravelle (urofollitropin) / Ferring
New P3 trial: FSH Treatment for Non-obstructive Azoospermic Patients (clinicaltrials.gov) - Oct 27, 2014
P3, N=200, Not yet recruiting, Sponsor: Azienda Sanitaria Locale Bari
- ||||| Menopur (menotropin) / Ferring
New P4 trial: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Oct 24, 2014
P4, N=150, Recruiting, Sponsor: Mansoura University
- ||| Firmagon (degarelix) / Astellas, Ferring
Enrollment open: ProComD: Therapy Pathways in the Treatment of Hormone Na (clinicaltrials.gov) - Oct 22, 2014
P=N/A, N=1500, Recruiting, Sponsor: Ferring Pharmaceuticals
N=36 --> 60 | Trial primary completion date: Feb 2015 --> Apr 2016 Not yet recruiting --> Recruiting
- Orencia (abatacept) / BMS, Actemra IV (tocilizumab) / Roche, JW Pharma, Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment status: NORD-STAR: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction (clinicaltrials.gov) - Oct 21, 2014
P4, N=800, Recruiting, Sponsor: Karolinska Institutet
Not yet recruiting --> Recruiting Recruiting --> Recruiting
- Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date, HEOR: RA-PROACTIVE: Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia (clinicaltrials.gov) - Oct 20, 2014
P=N/A, N=152, Active, not recruiting, Sponsor: UCB Pharma
Recruiting --> Recruiting Trial primary completion date: Nov 2015 --> Dec 2014
- |||| Bravelle (urofollitropin) / Ferring
Trial primary completion date, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females (clinicaltrials.gov) - Oct 17, 2014
P3, N=180, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Nov 2015 --> Dec 2014 Trial primary completion date: Sep 2014 --> Feb 2015
- Adstiladrin (nadofaragene firadenovec-vncg) / Ferring
Trial primary completion date: 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer (clinicaltrials.gov) - Oct 17, 2014
P1b, N=9, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Sep 2014 --> Feb 2015 Trial primary completion date: Jan 2015 --> Jan 2016
- ||||| Bravelle (urofollitropin) / Ferring
Enrollment change, Trial primary completion date, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program (clinicaltrials.gov) - Oct 17, 2014
P3, N=264, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Jan 2015 --> Jan 2016 N=200 --> 264 | Trial primary completion date: Sep 2014 --> Feb 2015
- Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: CRIB: A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta (clinicaltrials.gov) - Oct 2, 2014
P1, N=20, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
N=200 --> 264 | Trial primary completion date: Sep 2014 --> Feb 2015 Trial primary completion date: Jan 2015 --> Jul 2015
- Cimzia (certolizumab pegol) / Astellas, UCB
Trial initiation date, Trial primary completion date: CRADLE: A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia (clinicaltrials.gov) - Oct 2, 2014
P1b, N=16, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Trial primary completion date: Jan 2015 --> Jul 2015 Initiation date: Jun 2014 --> Sep 2014 | Trial primary completion date: May 2015 --> Oct 2015
- ||| Firmagon (degarelix) / Astellas, Ferring
Enrollment open: Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=200, Recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Jun 2014 --> Sep 2014 | Trial primary completion date: May 2015 --> Oct 2015 Not yet recruiting --> Recruiting
- | New P4 trial: Anti-TNF? Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Sep 19, 2014
P4, N=660, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Qu
- Menopur (menotropin) / Ferring
New P2/3 trial: Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins (clinicaltrials.gov) - Sep 11, 2014
P2/3, N=50, Not yet recruiting, Sponsor: University of Athens
- clomifene citrate / Generic mfg.
New P2/3 trial, Combination therapy: Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response. (clinicaltrials.gov) - Sep 11, 2014
P2/3, N=50, Not yet recruiting, Sponsor: University of Athens
- Menopur (menotropin) / Ferring
Trial initiation date, Trial primary completion date: Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF (clinicaltrials.gov) - Sep 10, 2014
P2/3, N=50, Not yet recruiting, Sponsor: University of Athens
Not yet recruiting --> Recruiting Initiation date: Apr 2014 --> Oct 2014 | Trial primary completion date: Sep 2014 --> Dec 2014
- Menopur (menotropin) / Ferring
Trial initiation date: Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur (clinicaltrials.gov) - Sep 10, 2014
P=N/A, N=371, Completed, Sponsor: University Hospital, Gasthuisberg
Initiation date: Apr 2014 --> Oct 2014 | Trial primary completion date: Sep 2014 --> Dec 2014 Initiation date: Nov 2005 --> Sep 2004
- Orencia (abatacept) / BMS, Actemra IV (tocilizumab) / Roche, JW Pharma, Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment change, Trial initiation date: NORD-STAR: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction (clinicaltrials.gov) - Sep 10, 2014
P4, N=300, Ongoing, Sponsor: The Karolinska Institute, ClinTRID`Glostrup Hospital, Videncenter for Reumatologi og Rygsygdomme, VRR`Karolinska Institutet
Initiation date: Nov 2005 --> Sep 2004 N=800 --> 300 | Initiation date: Dec 2012 --> May 2012
- Menopur (menotropin) / Ferring
Enrollment closed, Trial primary completion date: What is the Best Preparation for Embryo Transfer in Cryo Cycles: a Natural Cycle or Light Hormonal Stimulation? (clinicaltrials.gov) - Sep 10, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: University Hospital, Gasthuisberg
N=800 --> 300 | Initiation date: Dec 2012 --> May 2012 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2013 --> Oct 2013
- ||| Firmagon (degarelix) / Astellas, Ferring
Clinical: ProComD: Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. (clinicaltrials.gov) - Sep 9, 2014
P=N/A, N=1500, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- ||| Milprosa (progesterone vaginal ring) / Ferring
Trial completion: A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women (clinicaltrials.gov) - Sep 5, 2014
P1, N=56, Completed, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2013 --> Oct 2013 Active, not recruiting --> Completed
- ||| Firmagon (degarelix) / Astellas, Ferring
Clinical: Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer (clinicaltrials.gov) - Sep 4, 2014
P=N/A, N=200, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- ||||| Euflexxa (hyaluronic acid) / Ferring
Enrollment closed, Head-to-Head: Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ (clinicaltrials.gov) - Sep 4, 2014
P3, N=418, Active, not recruiting, Sponsor: Bioventus LLC
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Goofice (elobixibat) / Eisai, Mochida, Ipsen
Enrollment closed, Enrollment change, Trial primary completion date: Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation (clinicaltrials.gov) - Aug 29, 2014
P3, N=411, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting | N=900 --> 411 | Trial primary completion date: Oct 2015 --> May 2015
- Cervidil (dinoprostone) / Ferring
Enrollment open, Trial initiation date, Trial primary completion date: Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert (clinicaltrials.gov) - Aug 22, 2014
P4, N=253, Recruiting, Sponsor: Medical University of Graz
Enrolling by invitation --> Active, not recruiting | N=900 --> 411 | Trial primary completion date: Oct 2015 --> May 2015 Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> Nov 2013 | Trial primary completion date: Aug 2014 --> Dec 2014
- || Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment change: Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD) (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=1070, Recruiting, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> Nov 2013 | Trial primary completion date: Aug 2014 --> Dec 2014 N=500 --> 1070
- Firmagon (degarelix) / Astellas, Ferring
Enrollment open: TRial on the Endocrine Activity of Neoadjuvant Degarelix (clinicaltrials.gov) - Aug 19, 2014
P2, N=50, Recruiting, Sponsor: International Breast Cancer Study Group
N=500 --> 1070 Not yet recruiting --> Recruiting
- |||||| Testavan (transdermal testosterone gel 2%) / Ferring
Enrollment open: A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males (clinicaltrials.gov) - Aug 15, 2014
P3, N=142, Recruiting, Sponsor: Ferring Pharmaceuticals
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Rebyota (fecal microbiota, live-jslm) / Ferring
Trial completion: Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea (clinicaltrials.gov) - Aug 15, 2014
P2, N=40, Completed, Sponsor: Rebiotix Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||||| Merional (menotropin) / IBSA Institute Biochemical SA
Trial completion: Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients (clinicaltrials.gov) - Aug 15, 2014
P3, N=270, Completed, Sponsor: IBSA Institut Biochimique SA
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Elonva (corifollitropin alfa) / Organon
New P4 trial, HEOR, Cost effectiveness: Use of Corifolitropin Alfa in Oocyte Donors (clinicaltrials.gov) - Aug 11, 2014
P4, N=300, Not yet recruiting, Sponsor: IVI Madrid